Fresh Financial Statements From 2010 to 2024

FRTXDelisted Stock  USD 0.78  0.09  10.34%   
Fresh Tracks financial statements provide useful quarterly and yearly information to potential Fresh Tracks Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Fresh Tracks financial statements helps investors assess Fresh Tracks' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Fresh Tracks' valuation are summarized below:
Fresh Tracks Therapeutics does not presently have any fundamental signals for analysis.
Check Fresh Tracks financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresh Tracks' main balance sheet or income statement drivers, such as , as well as many indicators such as . Fresh financial statements analysis is a perfect complement when working with Fresh Tracks Valuation or Volatility modules.
  
This module can also supplement various Fresh Tracks Technical models . Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Fresh Tracks Therapeutics Company Profit Margin Analysis

Fresh Tracks' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Fresh Tracks Profit Margin

    
  (0.89) %  
Most of Fresh Tracks' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresh Tracks Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Fresh Tracks Therapeutics has a Profit Margin of -0.8933%. This is 92.03% lower than that of the Biotechnology sector and 96.12% lower than that of the Health Care industry. The profit margin for all United States stocks is 29.66% lower than that of the firm.

Fresh Tracks Therapeutics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Fresh Tracks's current stock value. Our valuation model uses many indicators to compare Fresh Tracks value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fresh Tracks competition to find correlations between indicators driving Fresh Tracks's intrinsic value. More Info.
Fresh Tracks Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Fresh Tracks by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Fresh Tracks' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Fresh Tracks Financial Statements

Fresh Tracks investors use historical fundamental indicators, such as Fresh Tracks' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Fresh Tracks. Please read more on our technical analysis and fundamental analysis pages.
Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado. Fresh Tracks operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Consideration for investing in Fresh Pink Sheet

If you are still planning to invest in Fresh Tracks Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fresh Tracks' history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
CEOs Directory
Screen CEOs from public companies around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio